Search

Meha Y Chhaya

from Shrewsbury, MA
Age ~60
Get Report
Also known as:
Chhaya Meha
Phone and address:
12 Bittersweet Cir, Shrewsbury, MA 01545
(508) 757-0686
Related to:
Nisarg G Chhaya, 34
Connected to:
Archana P Chhaya, 73Christina Chhe, 40Meng Chheang, 34Nenita D Chheang, 79Stephanie Chheang, 32Tony T Chheang, 70Vila Chheang, 34Ajay D Chheda, 56Dipesh N Chheda, 47Gaurav B Chheda, 34

Meha Chhaya Phones & Addresses

  • 12 Bittersweet Cir, Shrewsbury, MA 01545 (508) 757-0686
  • 1 Baron Park Ln, Burlington, MA 01803 (781) 221-1632
  • 1 Baron Park Ln #37, Burlington, MA 01803 (781) 221-1632

Work

Company: Abbvie Jul 2019 Position: Senior scientist ii

Skills

Drug Discovery • Cell Based Assays • In Vitro • Protein Purification • Purification • Cell Biology • Molecular Biology • Sds Page • Protein Chemistry • Cell Culture

Emails

m***[email protected]

Industries

Pharmaceuticals

Resumes

Resumes

Meha Chhaya Photo 1

Senior Scientist Ii

View page
Location:
Shrewsbury, MA
Industry:
Pharmaceuticals
Work:
Abbvie
Senior Scientist Ii
Skills:
Drug Discovery
Cell Based Assays
In Vitro
Protein Purification
Purification
Cell Biology
Molecular Biology
Sds Page
Protein Chemistry
Cell Culture

Publications

Us Patents

Anti-Ngf Antibodies And Their Use

View page
US Patent:
20130330348, Dec 12, 2013
Filed:
Aug 19, 2011
Appl. No.:
13/817721
Inventors:
Susan E. Lacy - Westborough MA, US
Jeffrey A. Barbon - Groton MA, US
Meha Chhaya - Shrewsbury MA, US
Emma Fung - Northborough MA, US
Charles W. Hutchins - Green Oaks IL, US
Diane M. Lang - Hope Valley RI, US
Eve H. Barlow - Wellesley MA, US
Mary Leddy - North Attleboro MA, US
Ravi Chari - Norwich CT, US
Assignee:
ABBOTT LABORATORIES - ABBOTT PARK IL
International Classification:
C07K 16/22
US Classification:
4241391, 5303873, 536 2353, 5303879
Abstract:
The present disclosure encompasses NGF binding proteins, specifically to antibodies that are chimeric, CDR grafted and canonized antibodies, and methods of making and uses thereof. The antibodies, or antibody portions, of the disclosure are useful for detecting NGF and for inhibiting NGF activity, e.g., in a mammal subject suffering from a disorder in which NGF activity is detrimental.

Anti-Ngf Antibodies And Their Use

View page
US Patent:
20180362629, Dec 20, 2018
Filed:
Aug 31, 2018
Appl. No.:
16/118757
Inventors:
- Louvain-La-Neuve, BE
Jeffrey A. Barbon - Groton MA, US
Meha Chhaya - Shrewsbury MA, US
Emma Fung - Northborough MA, US
Charles W. Hutchins - Green Oaks IL, US
Diane M. Lang - Hope Valley RI, US
Eve H. Barlow - Wellesley MA, US
Mary Leddy - North Attleboro MA, US
Ravi Chari - Norwich CT, US
International Classification:
C07K 16/22
A61K 39/395
G01N 33/566
A61K 39/00
Abstract:
The present disclosure encompasses NGF binding proteins, specifically to antibodies that are chimeric, CDR grafted and caninized antibodies, and methods of making and uses thereof. The antibodies, or antibody portions, of the disclosure are useful for detecting NGF and for inhibiting NGF activity, e.g., in a mammal subject suffering from a disorder in which NGF activity is detrimental.

Anti-Ngf Antibodies And Their Use

View page
US Patent:
20160264656, Sep 15, 2016
Filed:
Jul 14, 2015
Appl. No.:
14/799182
Inventors:
- Louvain-La-Neuve, BE
Jeffrey A. Barbon - Groton MA, US
Meha Chhaya - Shrewsbury MA, US
Emma Fung - Northborough MA, US
Charles W. Hutchins - Green Oaks IL, US
Diane M. Lang - Hope Valley RI, US
Eve H. Barlow - Wellesley MA, US
Mary Leddy - North Attleboro MA, US
Ravi Chari - Norwich CT, US
International Classification:
C07K 16/22
G01N 33/566
Abstract:
The present disclosure encompasses NGF binding proteins, specifically to antibodies that are chimeric, CDR grafted and canonized antibodies, and methods of making and uses thereof. The antibodies, or antibody portions, of the disclosure are useful for detecting NGF and for inhibiting NGF activity, e.g., in a mammal subject suffering from a disorder in which NGF activity is detrimental.

Anti-Ngf Antibodies And Their Use

View page
US Patent:
20160002324, Jan 7, 2016
Filed:
Jul 13, 2015
Appl. No.:
14/797719
Inventors:
- Louvain-La-Neuve, BE
Jeffrey A. Barbon - Groton MA, US
Meha Chhaya - Shrewsbury MA, US
Emma Fung - Northborough MA, US
Charles W. Hutchins - Green Oaks IL, US
Diane M. Lang - Hope Valley RI, US
Eve H. Barlow - Wellesley MA, US
Mary Leddy - North Attleboro MA, US
Ravi Chari - Norwich CT, US
International Classification:
C07K 16/22
Abstract:
The present disclosure encompasses NGF binding proteins, specifically to antibodies that are chimeric, CDR grafted and canonized antibodies, and methods of making and uses thereof. The antibodies, or antibody portions, of the disclosure are useful for detecting NGF and for inhibiting NGF activity, e.g., in a mammal subject suffering from a disorder in which NGF activity is detrimental.

Il-1 Binding Proteins

View page
US Patent:
20140178389, Jun 26, 2014
Filed:
Jul 12, 2013
Appl. No.:
13/940506
Inventors:
Susan E. LACY - Westborough MA, US
Lorenzo BENATUIL - Northborough MA, US
Meha CHHAYA - Shrewsbury MA, US
Emma FUNG - Northborough MA, US
Renee MILLER - N. Grosvenordale CT, US
Ravi CHARI - Norwich CT, US
Sarah J. HEIGHTON - Leominster MA, US
Jacqueline G. BIXBY - Auburn MA, US
Assignee:
ABBVIE, INC. - ABBOTT PARK IL
International Classification:
C07K 16/24
US Classification:
4241361, 5303873, 5303917, 5303913, 536 2353, 4353201, 435 696
Abstract:
The disclosure provides binding proteins that specifically bind to IL-1α and IL-1β. These binding proteins can be organized into DVD-Igs. These proteins can be used to modulate the activity of IL-1α and/or IL-1β and can be used for the treatment immunological diseases such as rheumatoid arthritis, osteoarthritis, psoriasis, multiple sclerosis, and other autoimmune diseases. In addition, their uses in the amelioration and/or treatment of pain in an individual suffering from a disease or disorder associated with IL-1 accumulation.
Control profile
Meha Y Chhaya from Shrewsbury, MA, age ~60 Get Report